- Home
- MTLS vs HUMA Comparison
MTLS vs HUMA Comparison
Compare MTLS & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTLS
- HUMA
- Stock Information
- Founded
- MTLS 1990
- HUMA 2004
- Country
- MTLS Belgium
- HUMA United States
- Employees
- MTLS N/A
- HUMA N/A
- Industry
- MTLS Computer Software: Prepackaged Software
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- MTLS Technology
- HUMA Health Care
- Exchange
- MTLS Nasdaq
- HUMA Nasdaq
- Market Cap
- MTLS 349.7M
- HUMA 250.2M
- IPO Year
- MTLS 2014
- HUMA N/A
- Fundamental
- Price
- MTLS $5.13
- HUMA $1.51
- Analyst Decision
- MTLS
- HUMA Strong Buy
- Analyst Count
- MTLS 0
- HUMA 8
- Target Price
- MTLS N/A
- HUMA $10.88
- AVG Volume (30 Days)
- MTLS 127.2K
- HUMA 5.9M
- Earning Date
- MTLS 10-23-2025
- HUMA 08-11-2025
- Dividend Yield
- MTLS N/A
- HUMA N/A
- EPS Growth
- MTLS N/A
- HUMA N/A
- EPS
- MTLS 0.11
- HUMA N/A
- Revenue
- MTLS $311,850,851.00
- HUMA $818,000.00
- Revenue This Year
- MTLS $2.98
- HUMA N/A
- Revenue Next Year
- MTLS $7.09
- HUMA $949.92
- P/E Ratio
- MTLS $48.31
- HUMA N/A
- Revenue Growth
- MTLS 2.98
- HUMA N/A
- 52 Week Low
- MTLS $3.93
- HUMA $1.15
- 52 Week High
- MTLS $9.69
- HUMA $6.77
- Technical
- Relative Strength Index (RSI)
- MTLS 47.90
- HUMA 36.87
- Support Level
- MTLS $5.01
- HUMA $1.43
- Resistance Level
- MTLS $5.32
- HUMA $1.67
- Average True Range (ATR)
- MTLS 0.18
- HUMA 0.15
- MACD
- MTLS 0.02
- HUMA -0.01
- Stochastic Oscillator
- MTLS 52.08
- HUMA 23.32
About MTLS Materialise NV
Materialise NV is a provider of 3D printing services. The products and services of the group are organized in three segments: Medical segment, which develops and delivers medical software solutions, medical devices, and other related products and services; Software segment, which develops and delivers additive manufacturing software solutions and related services; and Manufacturing segment, which delivers 3D printed products and related services. Its geographical segments are the United States, the Americas (excluding the USA), Belgium, Germany, France, Switzerland, the United Kingdom, Italy, the Netherlands, Other Europe, and the Asia Pacific.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.